Allocetra from Israel’s Enlivex Therapeutics (reported here previously) has cured the majority of the 37 seriously and critically ill Covid-19 patients in its Phase 1b and 2 trials. 33 patients were discharged from hospital an average of under 6 days … Continue reading →

Israel’s Ben Gurion University Professor Niv Papo discovered that tiny antibodies called nanobodies, found only in camels and sharks, can penetrate hard cancerous tissue to release chemotherapy treatments. BGU has bought a camel and have now begun trials on prostate … Continue reading →

Anonymous big data in the systems of Israel’s four medical companies (HMOs) is providing researchers with the information they need to solve medical problems. In the latest example, scientists from Israel’s Weizmann Institute used data from Clalit to document the … Continue reading →

Israel’s Therapix Biosciences (reported here previously) is working with the University of Calgary to evaluate the pain relief effect of its THX-160 analgesic. In pre-clinical studies, THX-160 was in some instances even more effective than high-dose morphine. http://therapix.investorroom.com/2020-12-02-Therapix-Biosciences-to-Collaborate-with-The-University-of-Calgary-to-Further-Examine-its-Proprietary-Drug-Candidate-THX-160-for-Pain https://therapixbio.com/

Israel’s Sol-Gel (reported here previously) has had its Twyneo acne treatment US FDA-approved following successful Phase 3 testing. https://ir.sol-gel.com/news-releases/news-release-details/sol-gel-technologies-announces-fda-acceptance-filing-new-drug-0

Israel’s Theranica (reported here previously) has received US FDA clearance to market its Nerivio therapeutic device for the acute treatment of episodic or chronic migraine in people 12 years and older. Theranica’s migraine patch was approved by the FDA in … Continue reading →